Legends leave Legacys~
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Please welcome @cherylshuman to the RFMK @VaporInhaler team! This is only the start of what's to come!
oOoYUPoOo
"The alliance will kick off with the focus on maximizing the health benefits of the new Vapor Inhaler's CANNAcig. "My plan is to make this product a 'star' by introducing CANNAcig and its health benefits to my celebrity and media connections. By implementing an aggressive product placement campaign in all of the top films and television shows, I'm confident that we will quickly dominate the market in sales and media exposure," states Shuman. "
The news today clearly indicates there will be much more to come~
Excited to see what endorsments will follow!
Big news for RFMK! Sounds like just the start with several prs to follow~
Cheryl Shuman Signs Global "First Look" Strategic Alliance Contract with Rapid Fire Marketing
Shuman will Act as Company Spokesperson and to Conduct Product Placement, Marketing and Consulting Services
Can someone post L2!?
Wow! Just saw the news!!!
You should just cover in the am.... Or wait n get burned...
Thats great!! Now back it up with what you know!?
Thats insane~
Viper Networks Signs LOI With Profitable Energy Reseller for Major Power Company in Northeast
Viper Networks, Inc. (Pink Sheets:VPER), is pleased to announce that the Company has taken a significant step to enter the U.S. energy sector by signing a Letter of Intent (LOI) with Aequitas Energy, Inc., a profitable energy reseller based in Connecticut that will soon be operating in multiple deregulated northeastern states.
Viper Networks' Chief Executive Officer met with Aequitas Energy's top executives at their New Haven, Connecticut headquarters last week and finalized terms yesterday (5/7/12) by signing an LOI agreement to invest $1,000,000.00 during 2012 to acquire 30% of the profitable energy company.
The vast majority of the Connecticut-based reseller's current broker energy source business is with one of the largest electric power generation companies nationwide. Additionally, Aequitas Energy is expected to begin operations as a reseller of natural gas in the near future.
The synergies, assets and key relationships that each company can offer; promises to create a rapidly expanding energy company that delivers energy power reliability, price stability and customer service excellence; along with the finest electric power efficiency standards nationally, new clean natural gas offerings and future renewable power choices, to include solar and/or wind power.
Acquisition plans are focused on major expansion into additional unregulated energy states throughout the U.S. and significant revenue growth through modest capital infusions that the Company has committed to raise.
Viper Networks, Inc.'s President and CEO, Mr. Farid Shouekani, commented: "As one of our top priorities this year, we have been working diligently to solidify a mutually beneficial relationship with this company. Since our commitment to enter the energy sector dovetails perfectly with our various energy-efficient, environmentally-friendly product sales and LED lighting agreements and projects, I am very happy to report that our recent fruitful meetings have produced a clear path to acquiring a notable percentage of Aequitas Energy. This event marks a significant step toward Viper Networks key diversification objectives, and the potential success for all shareholders going forward."
Please note the Company is displaying a 'temporary' corporate site at www.vipernetworks.com.
The Viper Networks, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=12434
Notice Regarding Forward-Looking Statements
This news release contains "forward-looking statements" as that term is defined in Section 27A of the United States Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development of new business opportunities, zero operational impact and projected costs, future operations, revenue, profits, gross margins and results of operations. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects and development stage companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate.
Can anyone post an L2!? (on my phone)
Ridiculous..
700k in buys the last 15 min??
OTC Stock in News; Cannabis Science Inc. (CBIS)
Cannabis Science Inc. (OTC: CBIS), a developer of pharmaceutical grade medical marijuana products, on Thursday, announced that it has teamed with Dr. Ivan Goldsmith of Trimcare in Las Vegas, Nevada.
CBIS and Dr. Goldsmith are teaming up to implement novel treatments for obesity, metabolic syndrome and hormone deficiency syndromes.
CBIS said that it is thrilled to welcome Dr. Goldsmith, who is a leading medical authority on weight management and patient self-esteem issues. He has two decades of experience and is triple board certified in Internal Medicine, Anti-Aging and Bariatrics.
Dr. Goldsmith’s Trimcare runs a weight loss program. It also focuses on cosmetic procedures. With CBIS, Trimcare will be actively involved in implementing breakthroughs from cutting edge research on the endocannabinoid system.
Dr. Goldsmith said that his mission has been to enhance wellness and life expectancy through product offerings.
CBIS shares fell sharply on Thursday. The stock ended the day 4.81% lower at $0.0890 on volume of 8.08 million.
So many loose ends on the recent PR's, who knows!?!?
I see huge potential here..
~Once the infusion of the product line/global marketing/CANCER CURE/Clinic/divy/funding/etc... comes to fruition, Cannabis Science will become a household name~
"You cant get the fruit unless you go out on a limb"
Stage 3 & 4 trials!~ The DD just keeps getting better here~
Lets look down the road here:
Cannabis Science is in FDA trials for a topical skin cream that sucks out the cancer and turns it into a scab that you just peel off!!
Who woulda thunk!?
~Possibilities here are limitless~
Longterm here will pay off$$
oOo I wonder what this could do for the people living in the southern hemisphere? With their shrinking ozone and skin cancer becoming more and more common... Hmmm...
Radiation is old and outdated...
Out with the old, in with the new!
http://www.drugs.com/clinical_trials/cannabis-science-reports-national-cancer-institute-updates-confirm-successful-cancer-treatments-11424.html
"Dr. Robert Melamede, CEO of Cannabis Science, noted that things have never been better for CBIS and this was confirmed at the conference over the past weekend. Dr. Melamede said that not only CBIS was part of a historic event, but the amount of consciousness and knowledge gained by everyone attending will also shape the medicinal science of the industry going forward. "
What "historic" event do you think he is refering too?
OTC Stock in News; Cannabis Science Inc. (CBIS)
Cannabis Science Inc. (OTC: CBIS), a development-stage company focused on the development of pharmaceutical grade medical cannabis products, earlier this week announced that it was a sponsor and exhibitor at the 7th national Patients Out of Time medical cannabis conference. The conference was held Tucson, Arizona and was attended by patients, doctors, nurses, pharmacists, professors, supporters and entrepreneurs of the medical cannabis industry.
CBIS said that it received some encouraging feedback by various representatives in the medical community during the conference. CBIS also collected data from attendees interested in CBIS Stock. The company saw significant interest in its new branding platform.
Dr. Robert Melamede, CEO of Cannabis Science, noted that things have never been better for CBIS and this was confirmed at the conference over the past weekend. Dr. Melamede said that not only CBIS was part of a historic event, but the amount of consciousness and knowledge gained by everyone attending will also shape the medicinal science of the industry going forward.
CBIS shares, which have seen huge activity in the last one month, are marginally lower in early trading today. At last check, the stock was down 2.55% to $0.0955 on volume of 2.56 million.
Also getting closer to a golden cross~
UNLEASH THE VIPER~
Nicely put~
Whats the news?
Well played~
Doesnt ATRN own/manage Blu ecigs? Correct me if im wrong but werent they just bought out for $135 mill?
Looks like the Viper came out of its hole~
http://stockcharts.com/c-sc/sc?s=VPER&p=D&b=5&g=0&i=t18674370379&r=1335478811262
Not really sure why your "LOL" at a product that was brought to fruition? That also brought the pps to a 52 week high of .03??
The bionic cig is old news for this company...
New CEO
http://rapid-fire-marketing.com/rapid-fire-marketing-announces-tom-allinder-new-ceo
New Management
http://rapid-fire-marketing.com/rapid-fire-marketing-executes-agreement-with-otherside-health-management
New Product
http://finance.yahoo.com/news/rapid-fire-marketing-announces-cannacig-132500633.html
Laying the foundation for a new company takes time!
~I know what i hold, ive done my research...
~Could careless about the pps currently...
~Not pleased one bit with the way things are going!
~But on the other hand im riding on "house shares" anyways:)
-I feel a unique game is being played here, smart trading goes further than concentrating on charts/news/hype
oOoHold when you knowoOo
@StockBang
@EliteYoda @VaporInhaler Sounds like a lot of juicy PR's are about to come down the pipe! $RFMK
Twitter for iPad • 4/24/12 8:46 PM
Cbis
Easy Linkage:
Cannabis Science, Inc. (OTCBB: CBIS) a pioneering U.S. biotech company developing pharmaceutical cannabis (marijuana) products, is thrilled to welcome Andrew Pitsicalis as International Brand and Licensing Director.
-When asked his thoughts were joining Cannabis Science Inc., Mr. Pitsicalis said, ”I look forward to creating great quality products. Having experience licensing properties that span a fan base of 2 billion people worldwide, I have licensed products in mass market retail stores around the globe. You can find Pitsicalis’ companies, licensed products in places like, Walmart, Target, Kohls, JC Penny, Urban Outfitters, Old Navy and other mass retail chains."
" -Leon Hendrix is pleased to endorse Cannabis Sciences’ role in creating great products his brother Jimi Hendrix would be proud of."
~Hmmmmmmm......
Cannabis Science’s COO Dr. Afaneh Provides Guidance On The Newest Over The Counter Product Line To Be Released
Cannabis Science, Inc. (OTCBB:CBIS.OB - News) a pioneering U.S. biotech company developing pharmaceutical cannabis and hemp products, has identified the four Cannabis Science brand products as the newest over the counter line to be released.
Cannabis science is among the leading experts specializing in developing all natural organic bio healing hemp health, beauty & cosmetics products. Our philosophy is to bring the best products possible to the entire world, to help improve & promote a healthier natural way of life with untold benefits. Our belief in achieving success is by providing superior products that are born from scientific data and research. From our years of dedication and hard work we have come to a new understanding in the keys to our product development.
Among our leading products is our sunscreen & protectant. Why our product is far superior to others is we have invested time into understanding what occurs in the body and skin, and targeting the cascade of events that occurs when people get sunburn. We have meticulously targeted key components that lead to the sunburn and have created our elite formulation that upon application, you instantly feel the skin begin to cool, the pain begins to dissipate and the healing process has begun. We have created our own cascade of healing properties using the finest natural ingredients to mimic or body’s natural pathway when responding to a skin burn. By combining certain ingredients that are coupled together produce a synergistic effect and also the sequence in which our ingredients are added into our formulation is key to our elite product.
Among our other popular topical skin care products, is our skin irritation for helping provide relief to various skin conditions such as eczema and other recurring skin irritations. We have looked at various populations and age groups that suffer from acute & chronic skin irritations. These symptoms varied from raised dry patches of skin, red blotches, hardened patches most appearing areas of the arms and legs, and a consistently itching from the histamine release of the body, as well as areas of the body that tended to constantly rub against clothing or other surfaces; including other parts of the body. Our specialized formulation was designed based on understanding what the patients’ expectations are from and over the counter skin care product. By understanding patients needs, we created our all natural unique formulation to help meet patients needs and improve their quality of life on daily basis. Our skin irritation cream targets the area thru multi-system approach. It is designed to help stop the itching and pain, first and foremost, and then begins to lock moisture in and around the area, and then our natural blend of ingredients begins to help the body heal the skin and reduce the irritation.
Among our novelty products is an anti-aging skin serum. Specifically formulated to meet the needs of woman and help rejuvenate and soften the skin. Using our science coupled with understanding what women expect from an anti-aging product, we used a multi-system approach to create the ultimate anti-aging serum. Using only natural ingredients, including hemp oil extract and many other natural oils and ingredients. Our serum helps to soften the skin, by providing key essential nutrients that are used in the right proportions and produced in a specialized combination; it leaves the skin looking radiant, energized, softer, healthier, and full of life.
Among our leading cosmetic products, is our all-natural lip balm that contains hemp oil extract and our unique blend of ingredients? Our lip balm is unique in that it has natural ingredients that help protect against bacteria and fungus, it also has SPF to protect against the harmful effects of the sun, infused with antioxidants and many other natural extracts it helps to soften the lips and lock the moisture in. Once again we used science and asked the right questions of our patients to understand their needs and what the expect from a lip balm. We achieved with our natural ingredients and extracts are able to meet those expectations; giving women the feeling of soft, juicy, radiant, and healthier looking lips.
The Cannabis Science executive team is finalizing negotiations for the manufacture and national distribution of this new product line. Commercialization is underway, including securing manufacturing partners with the resources to support the national distribution and retail outlets. Negotiations will continue when the first prototypes are received by Cannabis Science to be reviewed by various nationwide product distributors eagerly hoping to release this new line of products.
Do you where im going with this!?!?
Jan 30, 2012
FDA approves new treatment for most common type of skin cancer
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm289545.htm
Cannabis Science, Inc. (OTCBB:CBIS.ob), a pioneering US biotech company developing pharmaceutical cannabis products, is pleased to announce final negotiations to target an immediate European expansion with opportune acquisitions & licensing deals. This new set of deals is designed to bring to bring new products, revenues, and executive management to the company’s growing operations. The target European company has already created its footprint distributing its products in the European Markets and around the world while meeting Cannabis Science’s standards to ensure the utmost quality control and stringent procedures.
PRODUCT LINE COMING TOGETHER!
Im in the same boat~
"I put my money on the table for them to build RFMK into a strong company with a suite of products for a growing worldwide sector. "
Where are you getting 75 units?
Nice find!! That sounds very promising!$!
Sticky:
Cannabis Science Signs Andrew Pitsicalis as International Brand and Licensing Director, Rockin Artwork Grants Cannabis Science a License to Make Jimi Hendrix Image and Likeness Related Products for Advertising, Manufacturing, Sales and Marketing
Cannabis Science Inc.Posted on:20 Apr 12
Cannabis Science, Inc. (OTCBB: CBIS) a pioneering U.S. biotech company developing pharmaceutical cannabis (marijuana) products, is thrilled to welcome Andrew Pitsicalis as International Brand and Licensing Director.
Mr. Pitsicalis has been CEO of Rockin Artwork since 2010. Rockin Artwork is an intellectual property company, which manages or owns images and art by artists for Licensing and Fine Art. Their works include those by Mike and Dasha Biggs, David Garibaldi, Justin Farano, Dan Kennedy and more. Leon Hendrix, Jimi Hendrix's brother, is an owner and the spiritual guide of the company and their collection includes Jimi Hendrix images and art for merchandise and licensing.
Rockin Artwork has granted Cannabis Science a co-branding license to allow Cannabis Science to advertise, manufacture, and brand Jimi Hendrix images and likenesses and to make Jimi Hendrix image and likeness related products and the marketing thereof. Leon Hendrix is pleased to endorse Cannabis Sciences’ role in creating great products his brother Jimi Hendrix would be proud of.
When asked his thoughts were joining Cannabis Science Inc., Mr. Pitsicalis said, ”I look forward to creating great quality products. Having experience licensing properties that span a fan base of 2 billion people worldwide, I have licensed products in mass market retail stores around the globe. You can find Pitsicalis’ companies, licensed products in places like, Walmart, Target, Kohls, JC Penny, Urban Outfitters, Old Navy and other mass retail chains."
Mr. Pitsicalis’s role at Cannabis Science is to help build the brands of Cannabis Science. This will include consulting and brand management of Cannabis Science product lines, manufacture and develop the licensing platform for Cannabis Science, Patents and Trademarks. Mr. Pitsicalis will facilitate the advertising and licensing of products and branding of Cannabis Science. Pitsicalis will be selecting advertising campaigns for brand and product recognition. There are plans in the future to eventually license our biotechnology to pharmaceutical companies and other hemp related manufacturing licenses. Andrew has extensive connections to doctors, intellectual property, and venues for future medical cannabis conferences, all of which are invaluable to Cannabis Science.
Mr. Pitsicalis, legal victories in Federal Court for Jimi Hendrix Intellectual property rights will give Cannabis Science a seasoned component to licensing and branding. Andrew will be seated on the Policy Advisory Board for the company and we are pleased to have his input from his legal and licensing knowledge.
Cannabis Science is excited to welcome another talented and professional individual into the fold and looks forward to the endless promotion opportunities available through Andrew Pitsicalis.
About Cannabis Science, Inc.
Cannabis Science, Inc. is at the forefront of pharmaceutical grade medical marijuana research and development. The second formulations will address the needs of patients choosing to use concentrated cannabis extracts to treat their ailments. Eventually, all Americans will have access to a safe and effective FDA approved medicine regardless of which state they live in. To maintain that marijuana is a dangerous, addictive drug with no medical value is scientifically absurd. Cannabis medicines, with no effective lethal dose, are far safer than aspirin, acetaminophen, and most other OTC drugs that kill thousands of Americans every year.
The Company works with world authorities on phytocannabinoid science targeting critical illnesses, and adheres to scientific methodologies to develop, produce and commercialize phytocannabinoid-based pharmaceutical products. In sum, we are dedicated to the creation of cannabis-based medicines, both with and without psychoactive properties, to treat disease and the symptoms of disease, as well as for general health maintenance.
Forward Looking Statements
This Press Release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. A statement containing works such as "anticipate," "seek," intend," "believe," "plan," "estimate," "expect," "project," "plan," or similar phrases may be deemed "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Some or all of the events or results anticipated by these forward-looking statements may not occur. Factors that could cause or contribute to such differences include the future U.S. and global economies, the impact of competition, and the Company's reliance on existing regulations regarding the use and development of cannabis-based drugs. Cannabis Science, Inc. does not undertake any duty nor does it intend to update the results of these forward-looking statements.
www.cannabisscience.com
Business Wire
http://www.businesswire.com/
Last updated on: 20/04/2012 18:00:01
Haha, nice~